Phospho-p70 S6 Kinase Beta 2 (Tyr389) Rabbit Polyclonal Antibody

SKU: orb106095

Description

Phospho-p70 S6 Kinase Beta 2 (Tyr389) Rabbit Polyclonal Antibody

Research Area

Signal Transduction

Images & Validation

• Tested Applications: FC, IF, IHC-Fr, IHC-P, WB
• Dilution Range: WB=1:500-2000, IHC-P=1:100-500, IHC-F=1:100-500, IF=1:100-500, Flow-Cyt=1ug/Test
• Reactivity: Human, Mouse
• Predicted Reactivity: Bovine, Canine, Equine, Porcine, Rat

Key Properties

• Antibody Type: Primary Antibody
• Host: Rabbit
• Clonality: Polyclonal
• Isotype: IgG
• Immunogen: KLH conjugated Synthesised phosphopeptide derived from human RPS6KB2 around the phosphorylation site of Tyr389 FT(p-Y)VA
• Target: RPS6KB2
• Molecular Weight: 53 kDa
• Purification: Affinity purified by Protein A
• Conjugation: Unconjugated

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Form/Appearance: Liquid
• Buffer/Preservatives: 0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol.
• Concentration: 1mg/ml
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

KLS; P70-beta; P70-beta-1; P70-beta-2; S6K-beta2; S6K2; S6KB; S6KI(2); S6Kbeta; SRK; STK14B; p70(S6K)-beta; p70S6Kb; S6K-beta-2; KS6B2_HUMAN; RPS6KB2; 70 kDa ribosomal protein S6 kinase 2 (P70S6K2 | p70-S6K 2); S6 kinase-related kinase (SRK); Serine/threonine-protein kinase 14B; p70 ribosomal S6 kinase beta (S6K-beta | p70 S6 kinase beta | p70 S6K-beta | p70 S6KB | p70-beta); 2.7.11.1; KS6B2_MOUSE; 70 kDa ribosomal protein S6 kinase 2; p70 ribosomal S6 kinase beta (p70 S6 kinase beta | p70 S6K-beta | p70 S6KB); ribosomal protein S6 kinase B2; ribosomal protein S6 kinase, 70kD, polypeptide 2; RPS6KB2 | p70-S6K2 (phospho-Y389); p-p70-S6K2; phospho-p70-S6K2; p-RPS6KB2; RPS6KB2 | p70-S6K2 (phospho-Tyr389)

Quick Database Links

Gene Symbol

RPS6KB2

UniProt

Q9UBS0

Pal, Sumanta K. et al. RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma Mol Cancer Res, 13, 130-137 (2015)

PubMed: 25183163